Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia

Código QR

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia

Jeffrey R Bishop1,2, Mani N Pavuluri21Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA; 2Department of Psychiatry, Pediatric Mood Disorders Program and Center for Cognitive Medicine, University of Illinois at Chicago College of Medicine, Chicag...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jeffrey R Bishop, Mani N Pavuluri
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/114fb8b9e4014c84a4a5f1d80a3208a2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Risperidone treatment for ADHD in children and adolescents with bipolar disorder
por: Joseph Biederman, et al.
Publicado: (2008)

Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
por: Gao K, et al.
Publicado: (2013)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
por: Roberto Canitano, et al.
Publicado: (2008)

Emerging treatments in the management of bipolar disorder &ndash; focus on risperidone long acting injection
por: Wissam El-Hage, et al.
Publicado: (2010)

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
por: Ann E Maloney, et al.
Publicado: (2010)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
por: Hongkaew Y, et al.
Publicado: (2015)

Clinical utility of the risperidone formulations in the management of schizophrenia
por: Madaan V, et al.
Publicado: (2011)

Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
por: Hongyan Zhang, et al.
Publicado: (2011)

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
por: Zhao Y, et al.
Publicado: (2013)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar&nbsp;I disorder
por: Delia Bishara, et al.
Publicado: (2009)

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
por: Hong Liu-Seifert, et al.
Publicado: (2009)

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs L, et al.
Publicado: (2013)

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
por: El-Khalili N
Publicado: (2012)

Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder
por: A Carlo Altamura, et al.
Publicado: (2008)

Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
por: Louz&atilde; M, et al.
Publicado: (2011)

Association of Per3 length polymorphism with bipolar I disorder and schizophrenia
por: Karthikeyan R, et al.
Publicado: (2014)

A validation of wrist actigraphy against polysomnography in patients with schizophrenia or bipolar disorder
por: Baandrup L, et al.
Publicado: (2015)

Ziprasidone in the treatment of mania in bipolar disorder
por: Stephen E Nicolson, et al.
Publicado: (2007)

Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
por: Adel Gabriel
Publicado: (2010)

Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America
por: Mario Louz&atilde;, et al.
Publicado: (2010)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar F, et al.
Publicado: (2015)

The role of paliperidone extended release for the treatment of bipolar disorder
por: Marino J, et al.
Publicado: (2012)

Early stages of pediatric bipolar disorder: retrospective analysis of a Czech inpatient sample
por: Goetz M, et al.
Publicado: (2015)

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
por: Takahashi M, et al.
Publicado: (2012)

Risperidone for children and adolescents with autism spectrum disorder: a systematic review
por: Maneeton N, et al.
Publicado: (2018)

Facial expression in patients with bipolar disorder and schizophrenia in response to emotional stimuli: a partially shared cognitive and social deficit of the two disorders
por: Bersani G, et al.
Publicado: (2013)

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
por: Jean-Michel Azorin, et al.
Publicado: (2010)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
por: Prashant Gajwani, et al.
Publicado: (2007)

Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
por: Mannu P, et al.
Publicado: (2011)

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
por: McIntyre R, et al.
Publicado: (2011)

Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression
por: Haybaeck J, et al.
Publicado: (2015)

Differences in gray matter volume corresponding to delusion and hallucination in patients with schizophrenia compared with patients who have bipolar disorder
por: Song J, et al.
Publicado: (2015)

The efficacy of Li in bipolar disorder
por: Lozano R, et al.
Publicado: (2013)

Bipolar disorder and neurophysiologic mechanisms
por: Simon M McCrea
Publicado: (2008)

The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode
por: Findling RL, et al.
Publicado: (2014)

Treatment and prevention of mania in bipolar&nbsp;I disorder: focus on aripiprazole
por: David J Muzina
Publicado: (2009)

The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
por: Pompili M, et al.
Publicado: (2011)

The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder
por: Charles L Bowden
Publicado: (2011)

New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania
por: Warren CG, et al.
Publicado: (2013)

Sodium valproate-induced enuresis in a pediatric bipolar patient
por: Cheng W, et al.
Publicado: (2013)